Shetty A, Stewart K, Stewart G, Rice P, Danielian P, Templeton A
Department of Obstetrics and Gynaecology, Aberdeen Maternity Hospital, UK.
BJOG. 2002 Dec;109(12):1354-8. doi: 10.1046/j.1471-0528.2002.02082.x.
To compare the active management of term prelabour rupture of membranes with oral misoprostol with conservative management for 24 hours followed by induction with oxytocin or prostaglandin E(2) (PGE(2)) gel.
A non-blinded randomised controlled trial.
Induction and labour wards, Aberdeen Maternity Hospital.
Sixty-one women with confirmed prelabour rupture of the membranes at > or =36 weeks of gestation.
The women were randomised to 50 microg of oral misoprostol repeated every 4 hours, if required, to a maximum of five doses (active group), or to induction of labour with PGE(2) gel or oxytocin only if not in spontaneous labour 24 hours after prelabour rupture of membranes (conservative group).
Number of women in active labour within 24 hours of the prelabour rupture of membranes, preference of women for any one particular method of management in any subsequent pregnancy with prelabour rupture of membranes.
93.3% of the active group and 54.8% of the conservative group were in spontaneous labour within 24 hours of the prelabour rupture of membranes (RR 1.7, 95% CI 1.2 to 2.4). Of those achieving a vaginal delivery, 72% of the active group did so within 24 hours of the prelabour rupture of membranes as compared with 26.9% of the conservative group (RR 2.7, 95% CI 1.4 to 5.3, P = 0.002). There were no significant differences in the neonatal or maternal outcomes. In the active group, 78% felt they would have the same method of induction as compared with 40% in the conservative group (RR 1.9, 95% CI 1.1 to 3.3, P = 0.03).
Active management with oral misoprostol resulted in more women going into labour and delivering within 24 hours of the prelabour rupture of membranes with no increase in maternal or neonatal complications. Women tended to view active management of prelabour rupture of membranes more positively. Oral misoprostol might be an option to consider in those wishing active management.
比较足月胎膜早破采用口服米索前列醇的积极处理方法与保守处理24小时后再用缩宫素或前列腺素E₂(PGE₂)凝胶引产的方法。
非盲法随机对照试验。
阿伯丁妇产医院引产和分娩病房。
61例妊娠≥36周确诊为胎膜早破的妇女。
将这些妇女随机分为两组,若有需要,活性组每4小时重复口服50微克米索前列醇,最多5剂;保守组仅在胎膜早破24小时后仍未自然分娩时用PGE₂凝胶或缩宫素引产。
胎膜早破24小时内进入活跃期分娩的妇女数量,在随后任何一次妊娠发生胎膜早破时妇女对任何一种特定处理方法的偏好。
活性组93.3%的妇女和保守组54.8%的妇女在胎膜早破24小时内自然分娩(相对危险度1.7,95%可信区间1.2至2.4)。在经阴道分娩的妇女中,活性组72%在胎膜早破24小时内分娩,而保守组为26.9%(相对危险度2.7,95%可信区间1.4至5.3,P = 0.002)。新生儿及母亲结局无显著差异。活性组中,78%的妇女认为她们下次引产会采用相同方法,而保守组为40%(相对危险度1.9,95%可信区间1.1至3.3,P = 0.03)。
口服米索前列醇的积极处理方法使更多妇女在胎膜早破24小时内发动分娩并完成分娩,且未增加母亲或新生儿并发症。妇女对胎膜早破的积极处理方法倾向于给予更正面的评价。对于希望进行积极处理的患者,口服米索前列醇可能是一种可考虑的选择。